Tower Research Capital LLC (TRC) - ENDOCYTE INC ownership

ENDOCYTE INC's ticker is ECYT and the CUSIP is 29269A102. A total of 73 filers reported holding ENDOCYTE INC in Q4 2017. The put-call ratio across all filers is 1.41 and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of ENDOCYTE INC
ValueSharesWeighting
Q3 2018$144,000
+7100.0%
8,120
+5461.6%
0.01%
Q2 2018$2,000
-98.7%
146
-99.1%
0.00%
-100.0%
Q1 2018$149,000
+3625.0%
16,343
+1695.9%
0.01%
+1200.0%
Q4 2017$4,0009100.00%
Q3 2017$0
-100.0%
0
-100.0%
0.00%
-100.0%
Q2 2017$36,00023,841
+23741.0%
0.00%
Q4 2016$0
-100.0%
100
-97.8%
0.00%
-100.0%
Q2 2016$15,000
+200.0%
4,466
+169.7%
0.00%0.0%
Q1 2016$5,0001,656
+1235.5%
0.00%
Q4 2015$0
-100.0%
124
-98.6%
0.00%
-100.0%
Q3 2015$42,000
+20.0%
9,138
+38.1%
0.00%
+33.3%
Q2 2015$35,000
+400.0%
6,618
+473.0%
0.00%
+200.0%
Q4 2014$7,000
-72.0%
1,155
-71.8%
0.00%
-66.7%
Q3 2014$25,000
+733.3%
4,103
+811.8%
0.00%
Q2 2014$3,000
-95.3%
450
-83.1%
0.00%
-100.0%
Q1 2014$64,000
+204.8%
2,659
+39.6%
0.01%
+100.0%
Q4 2013$21,000
-61.1%
1,905
-52.6%
0.00%
-33.3%
Q3 2013$54,0004,0170.01%
Other shareholders
ENDOCYTE INC shareholders Q4 2017
NameSharesValueWeighting ↓
Corbenic Partners LLC 32,639$83,0000.09%
Anson Funds Management LP 108,426$276,0000.09%
Leisure Capital Management 30,038$77,0000.07%
HIGHLAND CAPITAL MANAGEMENT LP 461,561$1,177,0000.06%
Teza Capital Management LLC 14,542$37,0000.05%
PINNACLE ASSOCIATES LTD 821,543$2,095,0000.04%
Cribstone Capital Management, LLC 28,141$63,0000.04%
RMB Capital Management, LLC 243,385$621,0000.03%
Acrospire Investment Management LLC 26,061$66,0000.03%
TWO SIGMA SECURITIES, LLC 26,758$68,0000.02%
View complete list of ENDOCYTE INC shareholders